Greg's Alzheimer's Research Report

Greg's Alzheimer's Research Report

Part 13 - Lecanemab Overview

October 6, 2025

Greg Rowland's avatar
Greg Rowland
Jun 08, 2026
∙ Paid

During the past week, a lot of people have asked me about lecanemab. This is the medication I will be receiving by infusion every fourteen days starting October 14.

Lecanemab is an antibody medication used to treat early-stage Alzheimer’s disease. It works by removing beta-amyloid plaques, which are abnormal proteins that accumulate in the brains of people with Alzheimer’s disease.

User's avatar

Continue reading this post for free, courtesy of Greg Rowland.

Or purchase a paid subscription.
© 2026 Rowjera Holdings Inc · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture